Clinical trials query results
From Health Canada
- Medical condition:
- CORONAVIRUS DISEASE (COVID-19)
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- ACTEMRA (TOCILIZUMAB)
- Protocol title:
- A PROSPECTIVE, OBSERVATIONAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADJUNCTIVE HUMANIZED MONOCLONAL INTERLEUKIN 6 RECEPTOR ANTIBODY TOCILIZUMAB (TCZ) THERAPY TO STANDARD OF CARE FOR THE REDUCTION OF HYPERINFLAMMATION RELATED MORTALITY IN SARS-COV2 POSITIVE PATIENTS
- Sponsor name:
- UNIVERSITY OF CALGARY
- Date of no objection letter:
- 2020-05-22
- Control number:
- 239287
- Trial status:
- CLOSED
- Date study completed:
- 2021-10-26